Christopher Gharibo, MD
Pain Medicine · New York, NYNPI 1073500013
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.8%. Reporting peaked in 2019 at $41,697 and has fallen 60.3% since, to $16,549 in 2025. Among pain medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $1206.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$18K
- Tonix Medicines, Inc.$16K
- Daiichi Sankyo Inc.$11K
- Scilex Pharmaceuticals Inc.$11K
- Heron Therapeutics, Inc.$5K
- Pernix Therapeutics Holdings, Inc.$5K
- plus $24K from 15 others
Across 2 payments — averaging $3066.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo Pharmaceuticals Inc.$3K
- Purdue Pharma L.p.$3K
What the payments were for
- Consulting fees$50,80556%
- Speaking & faculty fees$31,21734%
- Travel & lodging$6,5787%
- Food & beverage$1,9092%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 2 | $17,925 |
| Tonix Medicines, Inc. | 7 | $16,406 |
| Daiichi Sankyo Inc. | 10 | $11,111 |
| Scilex Pharmaceuticals Inc. | 6 | $10,813 |
| Heron Therapeutics, Inc. | 14 | $5,002 |
| Pernix Therapeutics Holdings, Inc. | 1 | $4,950 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $4,595 |
| AstraZeneca | 1 | $3,750 |
| Tris Pharma Inc | 3 | $3,631 |
| Lilly USA, LLC | 1 | $3,000 |
| Pfizer | 3 | $2,970 |
| GRT US Holding, Inc. | 4 | $2,765 |
| Baudax Bio Inc. | 3 | $1,415 |
| Noven Pharmaceuticals, Inc. | 1 | $750 |
| Pacira Pharmaceuticals Incorporated | 1 | $675 |
| Boston Scientific | 3 | $361 |
| Nevro Corp. | 2 | $107 |
| Curonix LLC | 1 | $98 |
| Stimwave Technologies Incorporated | 1 | $68 |
| SPR Therapeutics, Inc | 1 | $66 |
| Pacira Therapeutics, Inc. | 1 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XTAMPZA$17,925
- BELBUCA$17,925
- Nucynta$12,000
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH$10,745
- TONMYA$8,404
- ZOHYDRO ER$4,950
- MOVANTIK$3,750
- LUCEMYRA$3,728
- HTX-011$3,205
- Qutenza$2,710
- Zynrelef$1,500
- ANJESO$1,415
- RELISTOR$857
- EXPAREL$675
- WaveWriter Alpha Prime 16$255
- WAVEWRITER ALPHA$106
How this compares
$90,509 in reported general payments places this provider in the 95th percentile of 503 pain medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 316 | $4,256 |
| Pregabalin | 70 | $2,140 |
| Gabapentin | 133 | $1,201 |
| Lidocaine | 13 | $1,029 |
| Tizanidine Hcl | 123 | $858 |
| Baclofen | 24 | $437 |
| Cyclobenzaprine Hcl | 12 | $40 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in New York
- Amitabh GulatiNew York$614K
- David SpinnerNew York$391K
- Eric LeeNew York$117K
- Randa JaafarNew York$87K
- Boris LeybelNew York$58K
- Chirag ShahNew York$48K
- Annie Layno-MosesNew York$29K
- Raj MurthyNew York$24K
- David CassagnolNew York$22K
- Scott MaddaloNew York$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.